Publication | Closed Access

Pharmacogenetic approach for capecitabine or 5-fluorouracil selection to be combined with oxaliplatin as first-line chemotherapy in advanced colorectal cancer

Pharmacogenetic ApproachMedicinePharmacologyColorectal CancerPharmacotherapyCancer TreatmentAdvanced Colorectal CancerOncologyRadiation OncologyCancer Research5-Fluorouracil Selection